Skip to content

Kantipur Pharmaceuticals Lab to issue IPO from November 26

nabil
global ime

Kathmandu. Kantipur Pharmaceuticals Lab Company is going to issue primary shares (IPO) from November 26. The company is going to issue IPO for the local residents of the project-affected areas and Nepalis who are in foreign employment.

The issued capital of the company will be 10% of the issued capital of the company i.e. 8 million units of face value of Rs 100 per unit for the locals of Panchkhal Municipality Ward No. 7 of Kavrepalanchowk District.

Similarly, the company is issuing 90,000 units of shares worth Rs 9 million i.e. 10% of the shares allotted to the general public.

Local residents can apply for a minimum of 10 units of shares and a maximum of 10,000 units of shares in the IPO. Nepalese working abroad can apply for a minimum of 10 units and a maximum of 7,000 units.

For the residents of the project-affected areas, the issue will be closed on December 9 at the earliest and on December 27 at the latest, while the Nepalese who are in foreign employment can apply for the IPO of the company till December 1. If the full application is not received by that period, the issue period will be extended till December 10.

Muktinath Capital Limited has been appointed as the issue manager for the IPO issuance. Locals of the project-affected areas can apply from the branches of Muktinath Bikas Bank and Sindhu Bikas Bank in Banepa and Panchkhal.

Local residents will have to pay a fee of Rs 2 for the application form to get the share purchase application. Nepalis who are in foreign employment can apply through the C-ASBA system using ‘Mero Share’, a software developed by all ASBA member banks and financial institutions approved by the Securities Board of Nepal and their designated branch offices and CDS and Clearing Limited.

Prabhu
sikhar insurance

प्रतिक्रिया दिनुहोस्

citizen life
MAK 4T